Study Analyzes Pharmaceutical Patient Education and Patient Advocacy
Posted on: Tuesday, 9 January 2007, 06:00 CST
RESEARCH TRIANGLE PARK, N.C., Jan. 9 /PRNewswire/ -- Pharmaceutical business intelligence leader Cutting Edge Information has announced the launch of a new industry study on the emerging topics of patient education, patient- focused communications among pharmaceutical companies, and patient advocacy (http://www.cuttingedgeinfo.com/studies/PH94survey.asp#body ).
Today's patients seek more information about their ailments than ever before. This creates an opportunity for pharmaceutical companies to connect with patients by providing them with reliable, unbiased health information. The study will investigate how pharmaceutical companies can successfully capitalize on this potential. By exploring companies' resource allocations, supporting structures, inherent challenges and unique marketing strategies, executives can learn from industry best practices to fine tune their own patient education efforts.
The study hits some of the hot questions surrounding patient education, such as:
-- How much does your company annually invest in patient education? -- What kinds of patient education materials does your company use? -- Does your company have any outcome measurements in place to determine ROI of your efforts? -- How has the advent of the Internet changed the way your company communicates with patients?
Analysts plan to delve deep into the topics most important to marketing executives. Visit http://www.cuttingedgeinfo.com/studies/PH94survey.asp#body today to learn how to participate in Cutting Edge Information's latest study on patient education and patient advocacy. Study participants will receive the full findings of the study when it is completed in early February.
"Within the scope of this study, we will also examine the pharmaceutical industry's relationship with patient advocacy groups," said Eric Bolesh, project team leader at Cutting Edge Information. "As pharma continues to be scrutinized by the public eye, these relationships will have to become more transparent and focused on increasing value for patients."
To participate in Cutting Edge Information's study on pharmaceutical patient education and patient advocacy, visit http://www.cuttingedgeinfo.com/studies/PH94survey.asp#body or contact Eric Bolesh at Eric_Bolesh@cuttingedgeinfo.com or 919-433-0209 for more information.
Cutting Edge Information
CONTACT: Eric Bolesh, of Cutting Edge Information, +1-919-433-0209, orEric_Bolesh@cuttingedgeinfo.com
Web site: http://www.cuttingedgeinfo.com/
Source: PRNewswire
Related Articles
- Physicians Have Less Respect For Obese Patients, Study Suggests
- Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
- Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients
- Hospital Improves Patient Experience by Adding Email and Web Access in Patient Rooms With Virtual Linux Desktops
- UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
- Study Finds Discontinuation of Rosiglitazone Left Many Diabetes Patients Without Good Glycemic Control
- PRA SPEAKING EVENT: Phase I Studies with Hepatitis C Compounds in Healthy Volunteers and Patients: Views from Inside
- Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
- Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
- CuraGen Announces Preliminary Data From Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients With Metastatic Melanoma
 |
 |
User Comments (0)
RSS Feeds